August 26,
2009
GenVec,
Inc.
65 West Watkins
Mill Road
Gaithersburg,
MD 20878
Ladies and
Gentlemen:
The undersigned (the “Investor”)
hereby confirms and agrees with you as follows:
1. This
Purchase Agreement (the “Agreement”) is made as of the
date hereof between GenVec, Inc., a Delaware corporation (the
“Company”), and the Investor that is a signatory to
this Agreement.
2. The
Company has authorized the sale and issuance of up to 8,000,000
shares of its common stock (the “Offered Shares”), par
value $0.001 per share (the “Common Stock”), and
warrants to purchase up to 4,000,000 shares of Common Stock (the
“Offered Warrants”) (the
“Offering”). The Offered Shares and the
Offered Warrants shall be sold together as units, each unit
consisting of one Offered Share and 0.50 Offered Warrants (the
“Warrant”) to purchase one share of Common Stock (such
units are referred to herein individually as the “Offered
Security” and collectively as the “Offered
Securities”). The exercise price of the Warrants
is $0.828 per share. The Offering is being made pursuant
to an effective shelf registration statement on Form S-3 (SEC File
No. 333-140373).
3. The
Company and the Investor agree that the Offering is being made
subject to the execution by the Company and the Placement Agent of
the Placement Agency Agreement, delivery of the prospectus
supplement dated the date hereof, delivery of the base prospectus
relating to the Offered Securities and delivery of additional
offering information, including pricing information. The
Company and the Investor agree that the Investor will purchase from
the Company and the Company will issue and sell to the Investor the
number of Offered Securities set forth below the Investor’s
name on Schedule I hereto, at a purchase price of $0.75 per share,
pursuant to the Terms and Conditions for Purchase of Offered
Securities attached hereto as Annex I and incorporated
herein by reference as if fully set forth herein. The
Investor acknowledges that the Offering is not being underwritten
by the Placement Agent and that there is no minimum offering
amount. Shares of Common Stock will be credited to the
Investor using customary book-entry procedures. The
executed Warrant will be delivered pursuant to the terms
thereof.
4. The
Investor represents that, except as set forth below, (a) it has had
no position, office or other material relationship within the past
three years with the Company or persons known to it to be
affiliates of the Company, (b) except as set forth on Schedule II
hereto, neither it, nor any group of which it is a member or to
which it is related, beneficially owns (including the right to
acquire or vote) any securities of the Company and (c) it is not a
FINRA member or a person associated with or affiliated with any
FINRA member as of the date hereof.
5. The
Investor confirms that it has had full access to all filings made
by the Company with the Securities and Exchange Commission,
including the registration statement and base prospectus relating
to the Offered Securities, and the documents incorporated by
reference therein, and that it was able to read, review, download
and print each such filing.
Please confirm that the foregoing correctly sets
forth the agreement between us by signing in the space provided
below for that purpose.
|
|
Name of Investor:
|
BAM Opportunity
Fund LP
|
AGREED AND
ACCEPTED:
GENVEC,
INC.
|
By:
|
/s/ Douglas J.
Swirsky
|
|
|
|
|
Name:
|
Douglas J.
Swirsky
|
|
|
|
|
Title:
|
Senior Vice
President, Chief Financial Officer,
Treasurer and
Corporate Secretary
|
SCHEDULE I
SCHEDULE OF
INVESTORS
|
Name of
Investor:
|
|
_________________________________
|
|
|
|
Name of
Individual Representing
Investor:
|
|
_________________________________
|
|
|
|
Title of
Individual Representing
Investor:
|
|
|
|
_________________________________
|
|
Address:
|
|
|
|
|
|
|
|
Telephone:
|
|
|
|
|
|
|
|
Telecopier:
|
|
|
|
Number of
Offered Shares
to Be Purchased
|
|
|
Number of
Offered Warrants
to be Purchased
|
|
|
Price Per
Offered Securities
In Dollars
|
|
|
Aggregate
Purchase
Price
|
|
|
|
8,000,000
|
|
|
|
4,000,000
|
|
|
$
|
0.75
|
|
|
$
|
6,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SCHEDULE II
SCHEDULE OF BENEFICIAL
OWNERSHIP
Please provide
the number of securities of GenVec, Inc. that you or your
organization will own immediately after Closing, including those
Offered Securities purchased by you or your organization pursuant
to this Purchase Agreement and those securities purchased or
acquired by you or your organization through other transactions and
provide the number of securities that you have or your organization
has the right to acquire within 60 days of Closing:
ANNEX I
TERMS AND CONDITIONS FOR PURCHASE
OF OFFERED SECURITIES
1.
Agreement to Sell and Purchase the Offered Securities; Placement
Agent.
1.1 Upon
the terms and subject to the conditions hereinafter set forth, at
the Closing (as defined in Section 2 below), the Company will sell
to the Investor, and the Investor will purchase from the Company,
the number of shares of Common Stock and the number of Warrants set
forth on Schedule I of this Agreement below such Investor’s
name at the purchase price set forth therein.
1.2 The
Company has entered into a Placement Agency Agreement (the
“Placement Agency Agreement”) dated the date hereof
with Merriman Curhan Ford & Co. in its capacity as Placement
Agent for the Offering (the “Placement Agent”), and the
Company has agreed to pay the Placement Agent a fee in respect of
the sale of the Common Stock and Warrants.
2.
Delivery of the Shares at Closing . The
completion of the purchase and sale of the Offered Securities (the
“Closing”) shall take place at a place and time (the
“Closing Date”) to be specified by the Company and the
Placement Agent, in accordance with Rule 15c6-1 promulgated under
the Securities Exchange Act of 1934, as amended (the
“Exchange Act”).
The Company’s obligation to issue
and sell the Offered Securities at Closing to the Investor shall be
subject to the accuracy of the representations and warranties made
by the Investor and the fulfillment of those undertakings of the
Investor to be fulfilled prior to the Closing.
The Investor’s obligation to
purchase the Offered Securities shall be subject to the condition
that the Placement Agent shall not have (a) terminated the
Placement Agency Agreement pursuant to the terms thereof or (b)
determined that the conditions to closing in the Placement Agency
Agreement have not been satisfied.
Prior to the Closing, the Investor shall
remit by wire transfer the amount of funds equal to the aggregate
purchase price for the Units being purchased by the Investor to an
account designated by the Placement Agent. Such funds
shall be held in escrow (without interest) until the Closing and
delivered by the Placement Agent (net of any commissions and
expense reimbursements payable to the Placement Agent pursuant to
the Placement Agency Agreement) on behalf of the Investors to the
Company upon the satisfaction, in the sole judgment of the
Placement Agent, of the conditions set forth in the foregoing
paragraph.
At the Closing, payment shall be made by,
or on behalf of, the Investor by release of funds by the Placement
Agent and the Company shall (a) deliver the Offered Shares
purchased by the Investor to the Investor through DTC directly to
the account(s) of the applicable DTC Holder as set forth on Annex
II and (b) deliver the Warrants to the Investors at the address set
forth on Annex II.
3.
Representations, Warranties and Covenants of the Company
. The Company hereby represents and warrants to, and
covenants with, the Investor, as follows:
3.1 The
issuance and sale of each of the Offered Shares and the Offered
Warrants have been